UPCOMING SESSIONS in ET
Wed, Apr 8, 2026
10:00 – 11:00 PM UTC
CAR-T Therapy for AL Amyloidosis: What’s New, What’s Real, and What’s Next Heather Landau Click To Register
UPCOMING SESSIONS in ET
Wed, Apr 8, 2026 · 10:00 – 11:00 PM UTC
CAR-T Therapy for AL Amyloidosis: What’s New, What’s Real, and What’s Next
Heather Landau
Click To Register
View all sessions

Giampaolo Merlini, MD

Dr. Giampaolo Merlini is the Director of the Center for Research and Treatment of Systemic Amyloidosis, and of the Biotechnology Research Laboratories, Scientific Institute Policlinico San Matteo, University of Pavia, Italy. He is Professor of Clinical Biochemistry at the University of Pavia and the President of the Post-Graduate Course in Medical Biotechnology. He is also the Past President of the International Society of Amyloidosis and Chairman of the Committee on Plasma Proteins, International Federation of Clinical Chemistry and Laboratory Medicine.
He attended the Medical School of the University of Pavia as an alumnus of the Ghislieri College. After being awarded his medical degree, he trained in clinical and laboratory investigation of monoclonal gammapathies at Malmo General Hospital, Lund University, Sweden.

Representative Publications:
First Name
Giampaolo
Last Name
Merlini
Address
IRCCS Policlinico San Matteo Hospital<br>
University of Pavia<br>
Viale Golgi 19
Qualification
Affiliation Info
Type of Expert
Phone
+39-382-502490
Country
Italy
City
Pavia
media
Image
giampaolo_merlini